Glucagon News and Research

RSS
Diabetic mice generate new insulin-producing cells following extreme cell destruction

Diabetic mice generate new insulin-producing cells following extreme cell destruction

Artificial pancreas system succeeds in maintaining near-normal glucose levels

Artificial pancreas system succeeds in maintaining near-normal glucose levels

Alpha cells in pancreas can convert into insulin-producing beta cells: Study

Alpha cells in pancreas can convert into insulin-producing beta cells: Study

NIH grant for study on impact of gastric bypass surgery on Type II diabetes patients

NIH grant for study on impact of gastric bypass surgery on Type II diabetes patients

Bariatric surgery may delay onset of type 2 diabetes, says study

Bariatric surgery may delay onset of type 2 diabetes, says study

New study shows leptin treatment may help reduce type 1 diabetes

New study shows leptin treatment may help reduce type 1 diabetes

NexACT technology demonstrates ability to deliver Taxol subcutaneously

NexACT technology demonstrates ability to deliver Taxol subcutaneously

NDA for BYDUREON: FDA issues complete response letter

NDA for BYDUREON: FDA issues complete response letter

Isis Pharmaceuticals reports revenues of $32.3M for fourth-quarter 2009

Isis Pharmaceuticals reports revenues of $32.3M for fourth-quarter 2009

Using genetic engineering techniques in pigs, scientists create new model of diabetes

Using genetic engineering techniques in pigs, scientists create new model of diabetes

Marcadia Biotech commences Phase 1 clinical trial of MAR701 for type 2 diabetes

Marcadia Biotech commences Phase 1 clinical trial of MAR701 for type 2 diabetes

MUHC commences clinical trial of Exsulin for type 1 diabetes

MUHC commences clinical trial of Exsulin for type 1 diabetes

Ipsen reports consolidated group sales of €1,032.8M for 2009

Ipsen reports consolidated group sales of €1,032.8M for 2009

Ligand Pharmaceuticals acquires Metabasis Therapeutics

Ligand Pharmaceuticals acquires Metabasis Therapeutics

FDA approves Victoza to treat type 2 diabetes in some adults

FDA approves Victoza to treat type 2 diabetes in some adults

FDA approves Novo Nordisk's Victoza for type 2 diabetes

FDA approves Novo Nordisk's Victoza for type 2 diabetes

Emisphere Technologies: Novo Nordisk initiates first Phase I clinical trial of GLP-1

Emisphere Technologies: Novo Nordisk initiates first Phase I clinical trial of GLP-1

Proprietary adult stem cell platform, an effective treatment for diabetes, shows study

Proprietary adult stem cell platform, an effective treatment for diabetes, shows study

Roche discloses results of two of eight taspoglutide T-emerge phase III studies in diabetes patients

Roche discloses results of two of eight taspoglutide T-emerge phase III studies in diabetes patients

Roche announces results of phase III taspoglutide study in diabetes patients

Roche announces results of phase III taspoglutide study in diabetes patients